| Drug Type Stem cell therapy | 
| Synonyms Autologous gammadelta T cell infusion therapy, Gammadelta T cell therapy Hemosol BioPharma + [1] | 
| Target- | 
| Action- | 
| Mechanism T lymphocyte replacements | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseDiscontinuedPhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Philadelphia chromosome positive chronic myelogenous leukemia | Phase 1 | Canada  | - | |
| Philadelphia chromosome positive chronic myelogenous leukemia | Phase 1 | United States  | - | 





